News | January 21, 2023
Marksans Pharma raises Rs. 372.40 crores
OrbiMed's exercise of warrant conversion will further strengthen the company's net cash position to over Rs.650 crores.
OrbiMed's exercise of warrant conversion will further strengthen the company's net cash position to over Rs.650 crores.
Sacu V is priced at Rs. 19 per tablet for a dose of 50 mg (sacubitril 24 mg + valsartan 26 mg)
Point-of-Care solution to facilitate clinicians in quick and effective decision making
The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
APAC to see a reduction in imported surgical robotics
The cardiomyopathies market in the 68M is set to grow at a CAGR of 12.1%
The implementing agency of PMBJP has invited online applications for opening of new Jan Aushadhi Kendras in 651 districts of different States/UTs
Palbociclib has a unique mechanism of action which helps in delaying disease progression when co-administered with hormonal therapies
Merck intends to complete today the acquisition of Imago through a merger of Merck’s wholly owned subsidiary with and into Imago
Chyawanprash Special will be available at all Jan Aushadhi Kendras
Subscribe To Our Newsletter & Stay Updated
